John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$230M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$207M |
| 3 |
EA
Electronic Arts
EA
|
+$205M |
| 4 |
Starbucks
SBUX
|
+$171M |
| 5 |
Baidu
BIDU
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$180M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$169M |
| 4 |
Walt Disney
DIS
|
+$168M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.51% |
| 2 | Technology | 14.81% |
| 3 | Industrials | 12.21% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Gaming and Leisure Properties
GLPI
$12.7B
| $42.6M | 0.17% |
1,319,388
+591,244
| +81% | +$20M |
|
152
Domino's
DPZ
$11.3B
| $42.5M | 0.17% |
171,463
-27,348
| -14% | -$7.2M |
|
153
Toll Brothers
TOL
$13.7B
| $42.5M | 0.17% |
1,289,403
+727,231
| +129% | +$23.4M |
|
154
Aramark
ARMK
$15.8B
| $42.3M | 0.17% |
2,020,625
+1,412,841
| +232% | +$36.7M |
|
155
Molina Healthcare
MOH
$10.5B
| $41.8M | 0.16% |
359,930
-478,786
| -57% | -$62.8M |
|
156
Citizens Financial Group
CFG
$29.4B
| $41.7M | 0.16% |
1,402,300
-1,180,038
| -46% | -$41.4M |
|
|
PFPT
157
DELISTED
Proofpoint, Inc.
PFPT
| $41.6M | 0.16% |
495,934
-254,564
| -34% | -$23.6M |
|
158
AGNC Investment
AGNC
$12.9B
| $41.5M | 0.16% |
2,364,400
-2,512,190
| -52% | -$44.8M |
|
159
Morgan Stanley
MS
$336B
| $41.1M | 0.16% |
1,037,415
-1,112,555
| -52% | -$48.6M |
|
160
Cheniere Energy
LNG
$57.3B
| $40.5M | 0.16% |
684,312
-769,210
| -53% | -$47.3M |
|
|
CLR
161
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $40.2M | 0.16% |
1,000,993
-315,402
| -24% | -$16.1M |
|
162
KLA
KLAC
$240B
| $40.2M | 0.16% |
4,489,860
+805,440
| +22% | +$7.5M |
|
163
Allstate
ALL
$64.2B
| $39.9M | 0.16% |
482,535
-943,487
| -66% | -$84.7M |
|
164
Colgate-Palmolive
CL
$72.6B
| $39.7M | 0.16% |
667,821
-1,618,704
| -71% | -$101M |
|
165
Ionis Pharmaceuticals
IONS
$9.93B
| $39.3M | 0.15% |
727,545
+187,876
| +35% | +$9.58M |
|
166
TSMC
TSM
$2.17T
| $39.2M | 0.15% |
1,063,119
-428,573
| -29% | -$16.3M |
|
167
Axalta
AXTA
$7.75B
| $39.2M | 0.15% |
1,673,278
-989,656
| -37% | -$24.6M |
|
168
EOG Resources
EOG
$80.3B
| $39.2M | 0.15% |
448,942
+306,840
| +216% | +$32.9M |
|
169
PUT
Amazon
AMZN
$2.79T
| $39.1M | 0.15% |
520,000
+40,000
| +8% | +$3.33M |
|
170
AT&T
T
$173B
| $38.8M | 0.15% |
1,800,607
-1,587,132
| -47% | -$36.9M |
|
171
IPG Photonics
IPGP
$3.12B
| $38.7M | 0.15% |
341,822
+183,021
| +115% | +$24.3M |
|
172
Sysco
SYY
$40.2B
| $38.1M | 0.15% |
608,832
-1,100,374
| -64% | -$74.2M |
|
173
Hilton Worldwide
HLT
$73.5B
| $38M | 0.15% |
529,365
+114,320
| +28% | +$8.26M |
|
174
Kinder Morgan
KMI
$69B
| $37.8M | 0.15% |
+2,457,008
| New | +$41.6M |
|
175
Ligand Pharmaceuticals
LGND
$5.71B
| $37.8M | 0.15% |
446,007
+304,619
| +215% | +$32.5M |
|
Similar funds
John Overdeck's Q4 2018 Portfolio in Review
As of Q4 2018, John Overdeck held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
John Overdeck withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, John Overdeck opened a new position in Starbucks worth $176M.
- John Overdeck's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
- John Overdeck added most to SLB Ltd in Q4 2018, an estimated $230M increase.
- John Overdeck's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
- John Overdeck fully exited Elevance Health in Q4 2018, selling an estimated $180M.
- John Overdeck's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
- John Overdeck opened 729 new positions and closed 943 in Q4 2018.
- John Overdeck's portfolio value fell 30% quarter-over-quarter to $25.5B.
Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.